PASCOE KEVIN CARLTON 4
4 · NATIONAL HEALTH INVESTORS INC · Filed Mar 5, 2025
Insider Transaction Report
Form 4
PASCOE KEVIN CARLTON
Chief Investment Officer
Transactions
- Award
Common Stock
2025-03-03+5,500→ 61,330 total - Award
Stock Option (Right to Buy) 2025
2025-03-03+15,000→ 15,000 totalExercise: $73.34From: 2025-03-03Exp: 2030-03-03→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy) 2025
2025-03-03+15,000→ 15,000 totalExercise: $73.34From: 2027-03-03Exp: 2030-03-03→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy) 2025
2025-03-03+15,000→ 15,000 totalExercise: $73.34From: 2026-03-03Exp: 2030-03-03→ Common Stock (15,000 underlying)
Holdings
- 8,500
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,500 underlying) - 8,500
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,500 underlying) - 8,500
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting March 3, 2026